The aim of the Bioproduction and Biotherapy Integrators Network (RIBB) is to coordinate, lead and assist the 8 integrators in the field of biotherapies and bioproduction, labelled as part of the ‘biotherapies and bioproduction of innovative therapies’ (SABB) acceleration strategy, so that they can fulfill their technological platform missions on behalf of academic or industrial partners, and facilitate the industrialisation of their technologies/products.